Get started
Author

Daisuke Kaya

Observed name: Kaya, Daisuke
ORCID: 0000-0003-2922-5679
Observed ORCID: 0000-0003-2922-5679
OpenAlex ID: A5075635152
Rifaximin Alleviates Endotoxemia with Decreased Serum Levels of Soluble CD163 and Mannose Receptor and Partial Modification of Gut Microbiota in Cirrhotic Patients
2020 · Kosuke Kaji, Soichiro Saikawa, et al. · Antibiotics · 46
PDF
Thyroid‐stimulating hormone is an independent risk factor of non‐alcoholic fatty liver disease
2019 · Kazuki Tahara, Takemi Akahane, et al. · JGH Open · 44
PDF
Effective Combination Therapy of Angiotensin-II Receptor Blocker and Rifaximin for Hepatic Fibrosis in Rat Model of Nonalcoholic Steatohepatitis
2020 · Yukihisa Fujinaga, Hideto Kawaratani, et al. · International Journal of Molecular Sciences · 39
PDF
Combined Treatment with Sodium-Glucose Cotransporter-2 Inhibitor (Canagliflozin) and Dipeptidyl Peptidase-4 Inhibitor (Teneligliptin) Alleviates NASH Progression in A Non-Diabetic Rat Model of Steatohepatitis
2020 · Takahiro Ozutsumi, Tadashi Namisaki, et al. · International Journal of Molecular Sciences · 29
PDF
TGR5 Activation Modulates an Inhibitory Effect on Liver Fibrosis Development Mediated by Anagliptin in Diabetic Rats
2019 · Daisuke Kaya, Kosuke Kaji, et al. · Cells · 26
PDF
Bile Acid Sequestrant, Sevelamer Ameliorates Hepatic Fibrosis with Reduced Overload of Endogenous Lipopolysaccharide in Experimental Nonalcoholic Steatohepatitis
2020 · Yuki Tsuji, Kosuke Kaji, et al. · Microorganisms · 24
PDF
Ancylostoma ceylanicum, novel etiological agent for traveler’s diarrhea—report of four Japanese patients who returned from Southeast Asia and Papua New Guinea
2018 · Masahide Yoshikawa, Yukiteru Ouji, et al. · Tropical Medicine and Health · 24
Glycogenic Hepatopathy in Type 1 Diabetes Mellitus
2017 · Shohei Asada, Hideto Kawaratani, et al. · Internal Medicine · 23
PDF
Association between Non-Alcoholic Fatty Liver Disease and Chronic Kidney Disease: A Cross-Sectional Study
2020 · Takemi Akahane, Manabu Akahane, et al. · Journal of Clinical Medicine · 22
PDF
Association between ADAMTS13 activity–VWF antigen imbalance and the therapeutic effect of HAIC in patients with hepatocellular carcinoma
2020 · Hiroaki Takaya, Tadashi Namisaki, et al. · World Journal of Gastroenterology · 20
The association between sarcopenia and endotoxin in patients with alcoholic cirrhosis
2021 · Shinya Sato, Tadashi Namisaki, et al. · Medicine · 16
Chronic Alcohol Consumption is Inversely Associated with Insulin Resistance and Fatty Liver in Japanese Males
2020 · Takemi Akahane, Tadashi Namisaki, et al. · Nutrients · 16
PDF
Effect of combined farnesoid X receptor agonist and angiotensin II type 1 receptor blocker on hepatic fibrosis
2017 · Tadashi Namisaki, Kei Moriya, et al. · Hepatology Communications · 16
PDF
Ancylostoma ceylanicum hookworm infection in Japanese traveler who presented chronic diarrhea after return from Lao People's Democratic Republic
2016 · Daisuke Kaya, Masahide Yoshikawa, et al. · Parasitology International · 16
Effect of combined farnesoid X receptor agonist and angiotensin II type 1 receptor blocker on ongoing hepatic fibrosis
2022 · Tadashi Namisaki, Kosuke Kaji, et al. · Indian Journal of Gastroenterology · 13
Combined effect of a farnesoid X receptor agonist and dipeptidyl peptidase‐4 inhibitor on hepatic fibrosis
2019 · Naotaka Shimozato, Tadashi Namisaki, et al. · Hepatology Research · 13
PDF
Accuracy of Fibrosis-4 Index in Identification of Patients with Cirrhosis Who Could Potentially Avoid Variceal Screening Endoscopy
2020 · Koji Ishida, Tadashi Namisaki, et al. · Journal of Clinical Medicine · 12
PDF
Identification of clinical risk factors for histological progression of primary biliary cholangitis
2019 · Yukihisa Fujinaga, Tadashi Namisaki, et al. · Hepatology Research · 12
Association between Equol Production Status and Nonalcoholic Steatohepatitis
2021 · Takemi Akahane, Daisuke Kaya, et al. · International Journal of Molecular Sciences · 11
PDF
Increased Endotoxin Activity Is Associated with the Risk of Developing Acute-on-Chronic Liver Failure
2020 · Hiroaki Takaya, Tadashi Namisaki, et al. · Journal of Clinical Medicine · 11
PDF
Proton pump inhibitor therapy does not increase serum endotoxin activity in patients with cirrhosis
2018 · Yasushi Okura, Tadashi Namisaki, et al. · Hepatology Research · 11
Efficacy and tolerability of interferon‑free regimen for patients with genotype‑1 HCV infection
2018 · Kosuke Takeda, Ryuichi Noguchi, et al. · Experimental and Therapeutic Medicine · 7
PDF
Severe toxicity of chemotherapy against advanced soft tissue sarcoma in Werner's syndrome: Ifosfamide-induced encephalopathy with central diabetes insipidus
2015 · Shinji Tsukamoto, Yukako Kurematsu, et al. · Journal of Orthopaedic Science · 7
Effectiveness of Lusutrombopag in Patients with Mild to Moderate Thrombocytopenia
2019 · Yuki Tsuji, Hideto Kawaratani, et al. · Digestive Diseases · 6
Effect of three or more treatments with lusutrombopag in patients with cirrhotic thrombocytopenia: A retrospective single‐center study
2020 · Hideto Kawaratani, Yuki Tsuji, et al. · Hepatology Research · 5
Works count: 39
Citation count: 479
H-index: 14
I10-index: 21
Year
Topic
Type